Öz
Toxoplasma gondii, hücre içi bir protozoan parazittir. Dünya nüfusunun yaklaşık %30’u Toxoplasma gondii ile enfektedir. Kronik olarak enfekte insanlarda, parazit doku kistleri özellikle beyinde bulunur. Nöropsikolojik bozuklukların nedenselliğinde, parazitolojik ajanların rolüne artan bir ilgi vardır. Bu derlemede; Toxoplasma spp. ile konağı arasındaki etkileşimleri, nöral ve psikolojik hastalık üzerine mekanizmaları ve sonuçları açıklanmıştır.
Anahtar Kelimeler: Nörobilim, Toxoplasma gondii, santral sinir sistemi, nöropsikoloji
Kaynakça
Black MW, Boothroyd JC. Lytic cycle of Toxoplasma gondii. Microbiol Mol Biol Rev 2000; 64: 607-23.
Halonen SK, Weiss LM. Toxoplasmosis. Handb Clin Neurol 2013; 114: 125-45.
Garcia LS (Ed.). Diagnostic Medical Parasitology (2007). e-ISBN: 9781555816018 ASM Press, Washington DC.
Remington JS, McLeod R, Desmonts G: Toxoplasmosis. In Remington JS, Klein JO (eds): Infectious Diseases of the Fetus and Newborn Infants, p 140-267. 4th ed. Philadelphia, WB Saunders, 1995.
Sibley LD, Boothroyd JC. Virulent strains of Toxoplasma gondii comprise a single clonal lineage. Nature 1992; 359: 82-5.
Howe DK, Honoré S, Derouin F, Sibley LD. Determination of genotypes of Toxoplasma gondii strains isolated from patients with toxoplasmosis. J Clin Microbiol 1997; 35: 1411-4.
Rajendran C, Su C, Dubey JP. Molecular genotyping of Toxoplasma gondii from Central and South America revealed high diversity within and between populations. Infect Genet Evol 2012; 12: 359-68.
Tyebji S, Seizova S, Hannan AJ, Tonkin CJ. Toxoplasmosis: A pathway to neuropsychiatric disorders. Neurosci Biobehav Rev 2019; 96: 72-92.
Feustel SM, Meissner M, Liesenfeld O. Toxoplasma gondii and the blood-brain barrier. Virulence 2012; 3: 182-92.
Ashour DS. Toxoplasma gondii: A journey into brain. ACTA Scientific Microbiology 2018; 1: 72-3.
KOZAR Z. Badania nad toksoplazmoza wsŕód umysłowo chorych [Studies on toxoplasmosis in mental diseases]. Biul Panstw Inst Med Morsk Trop J W Gdansku 1953; 5: 134-7.
Dos Santos Picanco LC, Ozela PF, de Fatima de Brito Brito M, Pinheiro AA, Padilha EC, Braga FS, et al. Alzheimer’s Disease: A Review from the Pathophysiology to Diagnosis, New Perspectives for Pharmacological Treatment. Curr Med Chem 2018; 25: 3141-59.
Alzheimer A. über eine eigenartige Erkrankung der Hirnrinde. Allgemeine Zeitschrift für Psychiatrie und Psychisch-Gerichtliche Medizin 1907; 64: 146-8.
Jung BK, Pyo KH, Shin KY, Hwang YS, Lim H, Lee SJ, et al. Toxoplasma gondii infection in the brain inhibits neuronal degeneration and learning and memory impairments in a murine model of Alzheimer’s disease. PLoS One 2012; 7: 33312.
Möhle L, Israel N, Paarmann K, Krohn M, Pietkiewicz S, Müller A, et al. Chronic Toxoplasma gondii infection enhances β-amyloid phagocytosis and clearance by recruited monocytes. Acta Neuropathol Commun 2016; 4: 25.
Kusbeci OY, Miman O, Yaman M, Aktepe OC, Yazar S. Could Toxoplasma gondii have any role in Alzheimer disease? Alzheimer Dis Assoc Disord 2011; 25: 1-3.
Mahami-Oskouei M, Hamidi F, Talebi M, Farhoudi M, Taheraghdam AA, Kazemi T, et al. Toxoplasmosis and Alzheimer: can Toxoplasma gondii really be introduced as a risk factor in etiology of Alzheimer? Parasitol Res 2016; 115: 3169-74.
Goodwin FK, Ghaemi SN. Bipolar disorder. Dialogues Clin Neurosci 1999; 1: 41-51.
Bergink V, Gibney SM, Drexhage HA. Autoimmunity, inflammation, and psychosis: a search for peripheral markers. Biol Psychiatry 2014; 75: 324-31.
Coccaro EF, Lee R, Groer MW, Can A, Coussons-Read M, Postolache TT. Toxoplasma gondii infection: relationship with aggression in psychiatric subjects. J Clin Psychiatry 2016; 77: 334-41.
Mitra R, Sapolsky RM, Vyas A. Toxoplasma gondii infection induces dendritic retraction in basolateral amygdala accompanied by reduced corticosterone secretion. Dis Model Mech 2013; 6: 516-20.
Pearce BD, Kruszon-Moran D, Jones JL. The relationship between Toxoplasma gondii infection and mood disorders in the third National Health and Nutrition Survey. Biol Psychiatry 2012; 72: 290-5.
Hamdani N, Daban-Huard C, Lajnef M, Richard JR, Delavest M, Godin O, et al. Relationship between Toxoplasma gondii infection and bipolar disorder in a French sample. J Affect Disord 2013; 148: 444-8.
de Barros JLVM, Barbosa IG, Salem H, Rocha NP, Kummer A, Okusaga OO, et al. Is there any association between Toxoplasma gondii infection and bipolar disorder? A systematic review and meta-analysis. J Affect Disord 2017; 209: 59-65.
Owen MJ, Sawa A, Mortensen PB. Schizophrenia. Lancet 2016; 388: 86-97.
Creuzet C, Robert F, Roisin MP, Van Tan H, Benes C, Dupouy-Camet J, et al. Neurons in primary culture are less efficiently infected by Toxoplasma gondii than glial cells. Parasitol Res 1998; 84: 25-30.
Mahmoudvand H, Ziaali N, Ghazvini H, Shojaee S, Keshavarz H, Esmaeilpour K, et al. Toxoplasma gondii Infection Promotes Neuroinflammation Through Cytokine Networks and Induced Hyperalgesia in BALB/c Mice. Inflammation 2016; 39: 405-12.
Tan L, Yu JT, Tan L. The kynurenine pathway in neurodegenerative diseases: mechanistic and therapeutic considerations. J Neurol Sci 2012; 323: 1-8.
Torrey EF, Bartko JJ, Lun ZR, Yolken RH. Antibodies to Toxoplasma gondii in patients with schizophrenia: a meta-analysis. Schizophr Bull 2007; 33: 729-36.
Brown AS, Schaefer CA, Quesenberry CP Jr, Liu L, Babulas VP, Susser ES. Maternal exposure to toxoplasmosis and risk of schizophrenia in adult offspring. Am J Psychiatry 2005; 162: 767-73.
Khandaker GM, Zimbron J, Lewis G, Jones PB. Prenatal maternal infection, neurodevelopment and adult schizophrenia: a systematic review of population-based studies. Psychol Med 2013; 43: 239-57.
Fond G, Macgregor A, Tamouza R, Hamdani N, Meary A, Leboyer M, et al. Comparative analysis of anti-toxoplasmic activity of antipsychotic drugs and valproate. Eur Arch Psychiatry Clin Neurosci 2014; 264: 179-83.
Robbins TW, Vaghi MM, Banca P. Obsessive-Compulsive Disorder: Puzzles and Prospects. Neuron 2019; 102: 27-47.
Nayeri Chegeni T, Sarvi S, Amouei A, Moosazadeh M, Hosseininejad Z, A Aghayan S, et al. Relationship between toxoplasmosis and obsessive compulsive disorder: A systematic review and meta-analysis. PLoS Negl Trop Dis 2019; 13: 0007306.
Driver JA, Logroscino G, Gaziano JM, Kurth T. Incidence and remaining lifetime risk of Parkinson disease in advanced age. Neurology 2009; 72: 432-8.
Mhyre TR, Boyd JT, Hamill RW, Maguire-Zeiss KA. Parkinson’s disease. Subcell Biochem 2012; 65: 389-455.
Takahashi H, Wakabayashi K. The cellular pathology of Parkinson’s disease. Neuropathology 2001; 21: 315-22.
Zhou Z, Zhou R, Li K, Wei W, Zhang Z, Zhu Y, et al. The Association between Toxoplasma gondii Infection and Risk of Parkinson’s Disease: A Systematic Review and Meta-Analysis. Biomed Res Int 2019; 2019: 8186017.
Leibowitz U, Antonovsky A, Medalie JM, Smith HA, Halpern L, Alter M. Epidemiological study of multiple sclerosis in Israel. II. Multiple sclerosis and level of sanitation. J Neurol Neurosurg Psychiatry 1966; 29: 60-8.
Strachan DP. Hay fever, hygiene, and household size. BMJ 1989; 299: 1259-60.
Stascheit F, Paul F, Harms L, Rosche B. Toxoplasma gondii seropositivity is negatively associated with multiple sclerosis. J Neuroimmunol 2015; 285: 119-24.
Ghadirian P, Dadgostar B, Azani R, Maisonneuve P. A case-control study of the association between socio-demographic, lifestyle and medical history factors and multiple sclerosis. Can J Public Health 2001; 92: 281-5.
Gustavsen MW, Page CM, Moen SM, Bjølgerud A, Berg-Hansen P, Nygaard GO, et al. Environmental exposures and the risk of multiple sclerosis investigated in a Norwegian case-control study. BMC Neurol 2014; 14: 196.
Saberi R, Sharif M, Sarvi S, Aghayan SA, Hosseini SA, Anvari D,et al. Is Toxoplasma gondii playing a positive role in multiple sclerosis risk? A systematic review and meta-analysis. J Neuroimmunol 2018; 322: 57-62.
Sanchack KE, Thomas CA. Autism Spectrum Disorder: Primary Care Principles. Am Fam Physician 2016; 94: 972-9.
Whiteley P, Haracopos D, Knivsberg AM, Reichelt KL, Parlar S, Jacobsen J, et al. The ScanBrit randomised, controlled, single-blind study of a gluten- and casein-free dietary intervention for children with autism spectrum disorders. Nutr Neurosci 2010; 13: 87-100.
Prandota J. Autism Spectrum Disorders May Be Due to Cerebral Toxoplasmosis Associated with Chronic Neuroinflammation Causing Persistent Hypercytokinemia that Resulted in an Increased Lipid Peroxidation, Oxidative Stress, and Depressed Metabolism of Endogenous and Exogenous Substances. Research in Autism Spectrum Disorders 2010; 4: 119-55.
Buie T. The relationship of autism and gluten. Clin Ther 2013; 35: 578-83.
Berenreiterová M, Flegr J, Kuběna AA, Němec P. The distribution of Toxoplasma gondii cysts in the brain of a mouse with latent toxoplasmosis: implications for the behavioral manipulation hypothesis. PLoS One 2011; 6: 28925.
Mahmoud ME, Ihara F, Fereig RM, Nishimura M, Nishikawa Y. Induction of depression-related behaviors by reactivation of chronic Toxoplasma gondii infection in mice. Behav Brain Res2 016; 298: 125-33.
Capuron L, Miller AH. Immune system to brain signaling: neuropsychopharmacological implications. Pharmacol Ther 2011; 130: 226-38.
Zorrilla EP, Luborsky L, McKay JR, Rosenthal R, Houldin A, Tax A, et al. The relationship of depression and stressors to immunological assays: a meta-analytic review. Brain Behav Immun 2001; 15: 199-226.
Miller AH, Maletic V, Raison CL. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry 2009; 65: 732-41.
Bressan RA, Costa DC, Jones HM, Ell PJ, Pilowsky LS. Typical antipsychotic drugs -- D(2) receptor occupancy and depressive symptoms in schizophrenia. Schizophr Res 2002; 56: 31-6.
Delgado García G, Rodríguez Perdomo E. Reactividad a la prueba intradérmica con toxoplasmina en enformos neuróticos y psicóticos maniacodepresivos [Reactivity of toxoplasmin intradermal test in neurotic and manic-depressive patients]. Rev Cubana Med Trop 1980; 32: 35-9.
Alvarado-Esquivel C, Sánchez-Anguiano LF, Hernández-Tinoco J, Berumen-Segovia LO, Torres-Prieto YE, Estrada-Martínez S, et al. Toxoplasma Gondii Infection and Depression: A Case–Control Seroprevalence Study. Eur J Microbiol Immunol (Bp) 2016; 6: 85-9.
Kar N, Misra B. Toxoplasma seropositivity and depression: a case report. BMC Psychiatry 2004; 4: 1.
Nayeri Chegeni T, Sharif M, Sarvi S, Moosazadeh M, Montazeri M, Aghayan SA, et al. Is there any association between Toxoplasma gondii infection and depression? A systematic review and meta-analysis. PLoS One 2019; 14: 0218524.
https://www.who.int/news-room/fact-sheets/detail/suicide [cited May 2020].
Gottlieb IH, Hammen CL. Handbook of Depression. New York (2002), Guilford Press.
Arling TA, Yolken RH, Lapidus M, Langenberg P, Dickerson FB, Zimmerman SA, et al. Toxoplasma gondii antibody titers and history of suicide attempts in patients with recurrent mood disorders. J Nerv Ment Dis 2009; 197: 905-8.
Lester D. Brain parasites and suicide. Psychol Rep 2010; 107: 424.
Yagmur F, Yazar S, Temel HO, Cavusoglu M. May Toxoplasma gondii increase suicide attempt-preliminary results in Turkish subjects? Forensic Sci Int 2010; 199: 15-7.
Bak J, Shim SH, Kwon YJ, Lee HY, Kim JS, Yoon H, Lee YJ. The Association between Suicide Attempts and Toxoplasma gondii Infection. Clin Psychopharmacol Neurosci 2018; 16: 95-102.
Fiest KM, Sauro KM, Wiebe S, Patten SB, Kwon CS, Dykeman J, et al. Prevalence and incidence of epilepsy: A systematic review and meta-analysis of international studies. Neurology 2017; 88: 296-303.
Ayaz E, Türkoğlu ŞA, Orallar H. Toxoplasma gondii and Epilepsy. Turkiye Parazitol Derg 2016; 40: 90-6.
Stommel EW, Seguin R, Thadani VM, Schwartzman JD, Gilbert K, Ryan KA, et al. Cryptogenic epilepsy: an infectious etiology? Epilepsia 2001; 42: 436-8.
Yazar S, Arman F, Yalçin S, Demirtaş F, Yaman O, Sahin I. Investigation of probable relationship between Toxoplasma gondii and cryptogenic epilepsy. Seizure 2003; 12: 107-9.
Akyol A, Bicerol B, Ertug S, Ertabaklar H, Kiylioglu N. Epilepsy and seropositivity rates of Toxocara canis and Toxoplasma gondii. Seizure 2007; 16: 233-7.
Ngoungou EB, Bhalla D, Nzoghe A, Dardé ML, Preux PM. Toxoplasmosis and epilepsy--systematic review and meta analysis. PLoS Negl Trop Dis 2015; 9: 0003525.
Hermes G, Ajioka JW, Kelly KA, Mui E, Roberts F, Kasza K, et al. Neurological and behavioral abnormalities, ventricular dilatation, altered cellular functions, inflammation, and neuronal injury in brains of mice due to common, persistent, parasitic infection. J Neuroinflammation 2008; 5: 48.
Carruthers VB, Suzuki Y. Effects of Toxoplasma gondii infection on the brain. Schizophr Bull 2007; 33: 745-51.
Fuks JM, Arrighi RB, Weidner JM, Kumar Mendu S, Jin Z, Wallin RP, et al. GABAergic signaling is linked to a hypermigratory phenotype in dendritic cells infected by Toxoplasma gondii. PLoS Pathog 2012; 8: 1003051.
Koseoglu E, Yazar S, Koc I. Is Toxoplasma gondii a causal agent in migraine? Am J Med Sci 2009; 338: 120-2.
Prandota J. The importance of toxoplasma gondii infection in diseases presenting with headaches. Headaches and aseptic meningitis may be manifestations of the Jarisch-Herxheimer reaction. Int J Neurosci 2009; 119: 2144-82.
Prandota J. Recurrent headache as the main symptom of acquired cerebral toxoplasmosis in nonhuman immunodeficiency virus-infected subjects with no lymphadenopathy: the parasite may be responsible for the neurogenic inflammation postulated as a cause of different types of headaches. Am J Ther 2007; 14: 63-105.
Hatter JA, Kouche YM, Melchor SJ, Ng K, Bouley DM, Boothroyd JC, et al. Toxoplasma gondii infection triggers chronic cachexia and sustained commensal dysbiosis in mice. PLoS One 2018; 13: 0204895.
Vittecoq M, Elguero E, Lafferty KD, Roche B, Brodeur J, Gauthier M, et al. Brain cancer mortality rates increase with Toxoplasma gondii seroprevalence in France Infection, Genetics and Evolution 2012; 12: 496-8.
